reported that increased expression of Nrf-2 in gliomas, coupled with decreased expression of Keap1, significantly accelerates cell proliferation, promotes tumor formation, and impedes programmed cell death (51) (Figure 11). The gene discussed is NFE2L2; the disease is neoplasm.